Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Piramal | Healthcare
247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893
Contact Piramal | Healthcare
Website

 Latest Content from PMHub 

The Power of Teamwork #LucidLife

Videos and Podcasts | August 30, 2019 | Lucid Group Communications Limited

At our summer meeting we came together to experience the real power of #teamwork through drumming, learning to listen and react as one voice #MedEd #MedComms #CompanyMeeting #AfricanDrumming #LucidLife

Apex launches Lumentium UK demo experience to pharma market

Press Releases | August 29, 2019 | Apex Events and Exhibitions

Something genuinely different has come to the UK events market.

Three strategies for managing loss of exclusivity successfully

White Papers and Resources | August 28, 2019 | Blue Latitude Health

Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.

Localising content: How to not get lost in translation

White Papers and Resources | August 28, 2019 | Anthill Agency

One of the biggest challenges in localising the content is that many of the parties involved in the process work in different systems and use different formats.

Empowered patients: shaking the foundations of healthcare

White Papers and Resources | August 21, 2019 | Blue Latitude Health

Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...

A uniquely English genomic medicine service

White Papers and Resources | August 20, 2019 | Blue Latitude Health

The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...

Blended Intelligence

White Papers and Resources | August 19, 2019 | Page & Page Health

Data is the most valued commodity of the modern world. For P&P it's all about the application.

Planning a pharma exhibition stand? You must read this!

Press Releases | August 19, 2019 | Apex Events and Exhibitions

Exhibitions and tradeshows are a powerful way to showcase your pharma brand and the products/services you offer. But it is vital to have an exhibition stand that works. Here are...

Putting our core values into practice at the Porterhouse summer social

Press Releases | August 15, 2019 | Porterhouse Medical Group

As a reward for all our hard work and in keeping with our core values, which include ‘family’ and ‘humour and happiness’, the teams at Porterhouse enjoy regular socials.For our...

Spotlight interview: 15 minutes on patient engagement in pharma

White Papers and Resources | August 14, 2019 | OPEN Health

Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma